Marta Kovatcheva

Title: Marta Kovatcheva: Innovator in Cancer Diagnostics

Introduction

Marta Kovatcheva is a prominent inventor based in New York, NY (US), known for her significant contributions to the field of cancer diagnostics. With a focus on developing companion diagnostics for CDK4 inhibitors, she has made strides in evaluating the effectiveness of cancer treatments.

Latest Patents

Marta holds 2 patents, including her latest innovations titled "Enigma" and "CDH18 as companion diagnostics for CDK4 inhibitors." These patents relate to the use of specific biomarkers to assess the likelihood of a CDK4 inhibitor producing an anti-cancer effect in patients. The disclosures emphasize methods, compositions, and kits designed to utilize the colocalization of Enigma and CDH18 biomarkers to determine the potential success of CDK4 inhibition in treating cancer.

Career Highlights

Marta Kovatcheva is affiliated with the Memorial Sloan Kettering Cancer Center, where she applies her expertise in cancer research and diagnostics. Her work is pivotal in advancing the understanding of how certain biomarkers can influence treatment outcomes for cancer patients.

Collaborations

Marta collaborates with esteemed colleagues, including Aimee Crago and Samuel Singer, to further her research and innovations in the field of cancer diagnostics.

Conclusion

Marta Kovatcheva's contributions to cancer diagnostics through her innovative patents and collaborative efforts highlight her role as a key figure in the ongoing fight against cancer. Her work continues to pave the way for more effective treatment options for patients.